Since chemoresistance is a hallmark of cancer stem cells, we next investigated the sensitivity of RANK OE cells to paclitaxel (PTX) and doxorubicin (Doxo), two chemotherapeutic agents commonly used to treat patients with breast cancer. The gene discussed is TNFRSF11A; the disease is breast carcinoma.